Report cover image

In Vitro Diagnostic Devices Industry Research Report 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 137 Pages
SKU # APRC20352388

Description

Summary

According to APO Research, The global In Vitro Diagnostic Devices market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for In Vitro Diagnostic Devices is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for In Vitro Diagnostic Devices is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for In Vitro Diagnostic Devices is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of In Vitro Diagnostic Devices include Abbott, Thermo Fisher Scientific, Roche, Wondfo, Sysmex, Siemens Healthineers, Qiagen, Ortho Clinical Diagnostics and Myriad Genetics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for In Vitro Diagnostic Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vitro Diagnostic Devices.
The In Vitro Diagnostic Devices market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global In Vitro Diagnostic Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

In Vitro Diagnostic Devices Segment by Company

Abbott
Thermo Fisher Scientific
Roche
Wondfo
Sysmex
Siemens Healthineers
Qiagen
Ortho Clinical Diagnostics
Myriad Genetics
Mindray
LG Chem
Leadman Biochemistry
KHB
Johnson and Johnson
Hologic
Danaher
DAAN Gene
BioSino
Bio-Rad Laboratories
Biomerieux
Becton Dickinson
In Vitro Diagnostic Devices Segment by Type

POCT
Molecular Diagnostics
Chemistry Diagnostics
Immuno Diagnostics
Other
In Vitro Diagnostic Devices Segment by Application

Hospitals
Laboratory
Other
In Vitro Diagnostic Devices Segment by Application

Hospitals
Laboratory
Other
In Vitro Diagnostic Devices Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In Vitro Diagnostic Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of In Vitro Diagnostic Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In Vitro Diagnostic Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of In Vitro Diagnostic Devices companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Table of Contents

137 Pages
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 In Vitro Diagnostic Devices by Type
2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031)
2.2.2 POCT
2.2.3 Molecular Diagnostics
2.2.4 Chemistry Diagnostics
2.2.5 Immuno Diagnostics
2.2.6 Other
2.3 In Vitro Diagnostic Devices by Application
2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.3.2 Hospitals
2.3.3 Laboratory
2.3.4 Other
2.4 Assumptions and Limitations
3 In Vitro Diagnostic Devices Breakdown Data by Type
3.1 Global In Vitro Diagnostic Devices Historic Market Size by Type (2020-2025)
3.2 Global In Vitro Diagnostic Devices Forecasted Market Size by Type (2026-2031)
4 In Vitro Diagnostic Devices Breakdown Data by Application
4.1 Global In Vitro Diagnostic Devices Historic Market Size by Application (2020-2025)
4.2 Global In Vitro Diagnostic Devices Forecasted Market Size by Application (2026-2031)
5 Global Growth Trends
5.1 Global In Vitro Diagnostic Devices Market Perspective (2020-2031)
5.2 Global In Vitro Diagnostic Devices Growth Trends by Region
5.2.1 Global In Vitro Diagnostic Devices Market Size by Region: 2020 VS 2024 VS 2031
5.2.2 In Vitro Diagnostic Devices Historic Market Size by Region (2020-2025)
5.2.3 In Vitro Diagnostic Devices Forecasted Market Size by Region (2026-2031)
5.3 In Vitro Diagnostic Devices Market Dynamics
5.3.1 In Vitro Diagnostic Devices Industry Trends
5.3.2 In Vitro Diagnostic Devices Market Drivers
5.3.3 In Vitro Diagnostic Devices Market Challenges
5.3.4 In Vitro Diagnostic Devices Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top In Vitro Diagnostic Devices Players by Revenue
6.1.1 Global Top In Vitro Diagnostic Devices Players by Revenue (2020-2025)
6.1.2 Global In Vitro Diagnostic Devices Revenue Market Share by Players (2020-2025)
6.2 Global In Vitro Diagnostic Devices Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of In Vitro Diagnostic Devices Head Office and Area Served
6.4 Global In Vitro Diagnostic Devices Players, Product Type & Application
6.5 Global In Vitro Diagnostic Devices Manufacturers Established Date
6.6 Global In Vitro Diagnostic Devices Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America In Vitro Diagnostic Devices Market Size (2020-2031)
7.2 North America In Vitro Diagnostic Devices Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 North America In Vitro Diagnostic Devices Market Size by Country (2020-2025)
7.4 North America In Vitro Diagnostic Devices Market Size by Country (2026-2031)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe In Vitro Diagnostic Devices Market Size (2020-2031)
8.2 Europe In Vitro Diagnostic Devices Market Growth Rate by Country: 2020 VS 2024 VS 2031
8.3 Europe In Vitro Diagnostic Devices Market Size by Country (2020-2025)
8.4 Europe In Vitro Diagnostic Devices Market Size by Country (2026-2031)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific In Vitro Diagnostic Devices Market Size (2020-2031)
9.2 Asia-Pacific In Vitro Diagnostic Devices Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Asia-Pacific In Vitro Diagnostic Devices Market Size by Country (2020-2025)
9.4 Asia-Pacific In Vitro Diagnostic Devices Market Size by Country (2026-2031)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America In Vitro Diagnostic Devices Market Size (2020-2031)
10.2 South America In Vitro Diagnostic Devices Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 South America In Vitro Diagnostic Devices Market Size by Country (2020-2025)
10.4 South America In Vitro Diagnostic Devices Market Size by Country (2026-2031)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa In Vitro Diagnostic Devices Market Size (2020-2031)
11.2 Middle East & Africa In Vitro Diagnostic Devices Market Growth Rate by Country: 2020 VS 2024 VS 2031
11.3 Middle East & Africa In Vitro Diagnostic Devices Market Size by Country (2020-2025)
11.4 Middle East & Africa In Vitro Diagnostic Devices Market Size by Country (2026-2031)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 Abbott
12.1.1 Abbott Company Information
12.1.2 Abbott Business Overview
12.1.3 Abbott Revenue in In Vitro Diagnostic Devices Business (2020-2025)
12.1.4 Abbott In Vitro Diagnostic Devices Product Portfolio
12.1.5 Abbott Recent Developments
12.2 Thermo Fisher Scientific
12.2.1 Thermo Fisher Scientific Company Information
12.2.2 Thermo Fisher Scientific Business Overview
12.2.3 Thermo Fisher Scientific Revenue in In Vitro Diagnostic Devices Business (2020-2025)
12.2.4 Thermo Fisher Scientific In Vitro Diagnostic Devices Product Portfolio
12.2.5 Thermo Fisher Scientific Recent Developments
12.3 Roche
12.3.1 Roche Company Information
12.3.2 Roche Business Overview
12.3.3 Roche Revenue in In Vitro Diagnostic Devices Business (2020-2025)
12.3.4 Roche In Vitro Diagnostic Devices Product Portfolio
12.3.5 Roche Recent Developments
12.4 Wondfo
12.4.1 Wondfo Company Information
12.4.2 Wondfo Business Overview
12.4.3 Wondfo Revenue in In Vitro Diagnostic Devices Business (2020-2025)
12.4.4 Wondfo In Vitro Diagnostic Devices Product Portfolio
12.4.5 Wondfo Recent Developments
12.5 Sysmex
12.5.1 Sysmex Company Information
12.5.2 Sysmex Business Overview
12.5.3 Sysmex Revenue in In Vitro Diagnostic Devices Business (2020-2025)
12.5.4 Sysmex In Vitro Diagnostic Devices Product Portfolio
12.5.5 Sysmex Recent Developments
12.6 Siemens Healthineers
12.6.1 Siemens Healthineers Company Information
12.6.2 Siemens Healthineers Business Overview
12.6.3 Siemens Healthineers Revenue in In Vitro Diagnostic Devices Business (2020-2025)
12.6.4 Siemens Healthineers In Vitro Diagnostic Devices Product Portfolio
12.6.5 Siemens Healthineers Recent Developments
12.7 Qiagen
12.7.1 Qiagen Company Information
12.7.2 Qiagen Business Overview
12.7.3 Qiagen Revenue in In Vitro Diagnostic Devices Business (2020-2025)
12.7.4 Qiagen In Vitro Diagnostic Devices Product Portfolio
12.7.5 Qiagen Recent Developments
12.8 Ortho Clinical Diagnostics
12.8.1 Ortho Clinical Diagnostics Company Information
12.8.2 Ortho Clinical Diagnostics Business Overview
12.8.3 Ortho Clinical Diagnostics Revenue in In Vitro Diagnostic Devices Business (2020-2025)
12.8.4 Ortho Clinical Diagnostics In Vitro Diagnostic Devices Product Portfolio
12.8.5 Ortho Clinical Diagnostics Recent Developments
12.9 Myriad Genetics
12.9.1 Myriad Genetics Company Information
12.9.2 Myriad Genetics Business Overview
12.9.3 Myriad Genetics Revenue in In Vitro Diagnostic Devices Business (2020-2025)
12.9.4 Myriad Genetics In Vitro Diagnostic Devices Product Portfolio
12.9.5 Myriad Genetics Recent Developments
12.10 Mindray
12.10.1 Mindray Company Information
12.10.2 Mindray Business Overview
12.10.3 Mindray Revenue in In Vitro Diagnostic Devices Business (2020-2025)
12.10.4 Mindray In Vitro Diagnostic Devices Product Portfolio
12.10.5 Mindray Recent Developments
12.11 LG Chem
12.11.1 LG Chem Company Information
12.11.2 LG Chem Business Overview
12.11.3 LG Chem Revenue in In Vitro Diagnostic Devices Business (2020-2025)
12.11.4 LG Chem In Vitro Diagnostic Devices Product Portfolio
12.11.5 LG Chem Recent Developments
12.12 Leadman Biochemistry
12.12.1 Leadman Biochemistry Company Information
12.12.2 Leadman Biochemistry Business Overview
12.12.3 Leadman Biochemistry Revenue in In Vitro Diagnostic Devices Business (2020-2025)
12.12.4 Leadman Biochemistry In Vitro Diagnostic Devices Product Portfolio
12.12.5 Leadman Biochemistry Recent Developments
12.13 KHB
12.13.1 KHB Company Information
12.13.2 KHB Business Overview
12.13.3 KHB Revenue in In Vitro Diagnostic Devices Business (2020-2025)
12.13.4 KHB In Vitro Diagnostic Devices Product Portfolio
12.13.5 KHB Recent Developments
12.14 Johnson and Johnson
12.14.1 Johnson and Johnson Company Information
12.14.2 Johnson and Johnson Business Overview
12.14.3 Johnson and Johnson Revenue in In Vitro Diagnostic Devices Business (2020-2025)
12.14.4 Johnson and Johnson In Vitro Diagnostic Devices Product Portfolio
12.14.5 Johnson and Johnson Recent Developments
12.15 Hologic
12.15.1 Hologic Company Information
12.15.2 Hologic Business Overview
12.15.3 Hologic Revenue in In Vitro Diagnostic Devices Business (2020-2025)
12.15.4 Hologic In Vitro Diagnostic Devices Product Portfolio
12.15.5 Hologic Recent Developments
12.16 Danaher
12.16.1 Danaher Company Information
12.16.2 Danaher Business Overview
12.16.3 Danaher Revenue in In Vitro Diagnostic Devices Business (2020-2025)
12.16.4 Danaher In Vitro Diagnostic Devices Product Portfolio
12.16.5 Danaher Recent Developments
12.17 DAAN Gene
12.17.1 DAAN Gene Company Information
12.17.2 DAAN Gene Business Overview
12.17.3 DAAN Gene Revenue in In Vitro Diagnostic Devices Business (2020-2025)
12.17.4 DAAN Gene In Vitro Diagnostic Devices Product Portfolio
12.17.5 DAAN Gene Recent Developments
12.18 BioSino
12.18.1 BioSino Company Information
12.18.2 BioSino Business Overview
12.18.3 BioSino Revenue in In Vitro Diagnostic Devices Business (2020-2025)
12.18.4 BioSino In Vitro Diagnostic Devices Product Portfolio
12.18.5 BioSino Recent Developments
12.19 Bio-Rad Laboratories
12.19.1 Bio-Rad Laboratories Company Information
12.19.2 Bio-Rad Laboratories Business Overview
12.19.3 Bio-Rad Laboratories Revenue in In Vitro Diagnostic Devices Business (2020-2025)
12.19.4 Bio-Rad Laboratories In Vitro Diagnostic Devices Product Portfolio
12.19.5 Bio-Rad Laboratories Recent Developments
12.20 Biomerieux
12.20.1 Biomerieux Company Information
12.20.2 Biomerieux Business Overview
12.20.3 Biomerieux Revenue in In Vitro Diagnostic Devices Business (2020-2025)
12.20.4 Biomerieux In Vitro Diagnostic Devices Product Portfolio
12.20.5 Biomerieux Recent Developments
12.21 Becton Dickinson
12.21.1 Becton Dickinson Company Information
12.21.2 Becton Dickinson Business Overview
12.21.3 Becton Dickinson Revenue in In Vitro Diagnostic Devices Business (2020-2025)
12.21.4 Becton Dickinson In Vitro Diagnostic Devices Product Portfolio
12.21.5 Becton Dickinson Recent Developments
13 Report Conclusion
14 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.